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Review question/objective 
The objective of this review is to identify the effectiveness of surveillance systems and community-
based interventions in identifying and responding to emerging and re-emerging zoonotic infections in 
Southeast Asia (SE Asia).  
More specifically the research questions are: 
1. What is the effectiveness of community-based surveillance interventions designed to identify 
emerging zoonotic infectious diseases?  
2. What is the effectiveness of non-pharmaceutical community-based interventions designed to 
prevent transmission of emerging zoonotic infectious diseases?  
3. How do factors related to the emergence and management of emerging zoonotic infectious 
diseases impact the effectiveness of interventions designed to identify and respond to them?  
2 
 
Background 
The 2004 WHO/FAO/OIE joint consultation on emerging zoonotic diseases defined them as, "a 
zoonosis that is newly recognized or newly evolved, or that has occurred previously but shows an 
increase in incidence or expansion in geographical, host or vector range" 1. Avian influenza, severe 
acute respiratory syndrome (SARS), coronavirus, Nipah virus, monkeypox, Hendra virus, and the 
lentiviruses that cause AIDS are a few examples of the growing number of diseases that humans can 
contract from animals.  
The Asia Pacific Region has, unfortunately, been at the epicentre of such epidemics. Over 30 new 
infectious agents have been detected in the last three decades, 75% of which have originated in 
animals (zoonoses). 2 Zoonotic diseases are predicted to cause an increased economic and health 
burden in this region. A number of factors contribute to these circumstances. The absence of effective 
surveillance and control programs, prevailing sociocultural practices and weak public health and 
veterinary services infrastructure exacerbates the vulnerability of these settings. Other factors 
including climate change, environmental degradation, encroachment of humans on areas where 
wildlife exists, cohabitation of humans and food animals within households, and the mixing of species 
in live animal markets play a role in increased disease transmission.  
Influenza A remains a global priority as although it usually causes only minor disease, it can cause 
epidemics. Approximately 10% to 15% of people worldwide contract influenza annually, with attack 
rates as high as 50% during major epidemics. 3 Global pandemic viral infections have been 
devastating. In 2003 the SARS epidemic affected around 8000 people and killed 780. In 2006 a new 
avian H5N1, and in 2009 a new H1N1 'swine' influenza pandemic threat, caused widespread anxiety.4 
In addition to mortality and morbidity these diseases can cause huge economic losses. The economic 
cost of the major outbreaks of new epidemic zoonotic diseases over the past decade, including SARS 
and H5N1influenza, has been estimated to be $200 billion. 4  
To prevent and control zoonotic infections in SE Asia, a multi-sectoral and multi-disciplinary approach, 
involving many levels of the health and non-health sector, is needed, which places a strong emphasis 
on both the early detection and early control of infectious disease outbreaks.  
Surveillance activities 
Early detection of disease outbreaks requires effective disease surveillance systems. Systems in 
developing countries face many operational challenges, including a lack of accurate and timely 
information exchange between local, provincial, national and regional levels, and inadequate human 
resource and laboratory capacity for speedy diagnosis. The WHO’s Asia Pacific Strategy for 
Emerging Diseases 2010 highlights the need for community involvement in surveillance, 2 but there 
are no guidelines for which types of emerging diseases should be reported or how developing 
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countries should conduct surveillance. Zoonotic disease detection and control also depends on 
effective veterinary surveillance and the ability to contain outbreaks amongst animal populations, 
systems that are often poorly developed or non-existent in developing countries. 
Jones et al. 5 suggests that local targeted surveillance of at-risk people may be the best way to 
prevent large-scale emergence. Brownstein et al. 6 in their discussion of web surveillance suggest that 
the use of news media and other non-traditional sources of surveillance data such as web-accessible 
discussion sites and disease reporting networks could facilitate early outbreak detection and increase 
public awareness of disease outbreaks prior to their formal recognition. May et al. 7 review the 
evidence for syndromic surveillance systems in developing countries (systems utilising existing clinical 
data prior to a diagnosis) and find that this may be a feasible and effective approach to infectious 
disease surveillance in developing countries.  
Evaluating surveillance activities 
The effectiveness of surveillance systems in responding generally to emerging infectious diseases 
has not been reviewed systematically. Reviews aimed at particular contexts (for example, prevention 
of bioterrorism 8 and public health surveillance for trachoma2) have been undertaken, however, 
neither review was able to state whether surveillance systems are achieving the ultimate goal of 
detecting outbreaks early and providing an accurate picture of infection rates in the area covered by 
the surveillance program. 2 
Most evaluations of surveillance programs have been qualitative and focused on evaluating the 
practical structure and operation of the system rather than its impact on infectious disease 
transmission. 9-11 Many researchers have used the Centers for Disease Control and Prevention (CDC) 
guideline which recommends how a surveillance system can be assessed to verify if it meets its 
objectives. 12 This provides a framework for evaluating how well a system is functioning and 
determining reasons why it may or may not be functioning to detect and respond to infectious disease 
outbreaks and/or support ongoing control activities to tackle endemic diseases.  
The CDC guideline recommends that reports of surveillance systems include the following:  
 descriptions of the public health importance of the health event under surveillance; the system 
under evaluation; the direct costs needed to operate the system; the usefulness of the 
system;  
 evaluations of the system’s simplicity, stability (its ability to withstand external changes), 
flexibility (that is, “the system’s ability to change as surveillance needs change”), acceptability 
(“as reflected by the willingness of participants and stakeholders to contribute to the data 
collection, analysis and use”), sensitivity to detect outbreaks, positive predictive value of 
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system alarms for true outbreaks, representativeness of the population covered by the 
system, and timeliness of detection. 
Prevention and control activities 
Control of emerging infectious disease requires an effective response to surveillance data. Single 
measures such as the use of vaccines or antiviral drugs may be unavailable, unaffordable or not in 
sufficient quantity. The control of these infectious diseases in resource constrained settings is more 
likely to be influenced by community-based and behavioural change interventions as well as by 
strengthening of national and international commitment to their control. 13 Over the last decade there 
have been increased efforts to promote community-based infectious disease control .2 
For vector-borne infections, such as dengue, attention has been focused on interventions to reduce 
larval, and ultimately adult, vector populations. Programs have attempted to achieve this via a range 
of chemical, biological and physical interventions to reduce vector populations, as well as trying to 
initiate behavioural change at the community level to prevent contact with the mosquito vectors. 14 
Heintze et al. have previously reviewed the evidence for community-based dengue control 
programs15. This review completed in 2005 found at that time that the evidence for these activities 
was weak and inconclusive and suggested a number of priorities for future research in this area. 
However, the review has not since been updated.    
Community-based interventions to control the spread of respiratory viruses, such as influenza, have 
focused on hygiene and respiratory etiquette to prevent human to human transmission. Many of these 
interventions have only been evaluated in a developed country context. Aledort et al. 16 and Jefferson 
et al. 13 undertook systematic reviews of physical interventions to interrupt or reduce the spread of 
respiratory viruses. Both reviews found handwashing was effective whilst there was no evidence to 
support school/workplace closure. However these findings from a predominantly North American 
context may not be generalisable to countries with limited access to safe water and sanitation.  
Evaluating control activities 
To understand whether community-based control activities will be effective and why requires us to 
look at the behavioural mechanisms through which these interventions work and the context in which 
they are based. Behavioural mechanisms operate through the experiences, beliefs and values of 
groups and individuals. These mechanisms are therefore dependent in part on the context in which 
they are used. This framework was used in a recent synthetic review of water and sanitation projects. 
17 The framework is shown in Figure 1. 
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Measuring outcomes 
For the purposes of this review, a number of different outcomes will be examined, broadly categorised 
into primary and secondary outcomes. Primary outcomes are measures of infection or disease in the 
community. As such we will consider studies that report any type of quantitative 
infection/disease/outbreak outcome data. We will also consider data on morbidity and mortality rates 
attributable to the infectious disease.  
Secondary outcomes are other indicators of the effectiveness of a surveillance and/or control 
program. These indicators can be used as intermediate outcomes to predict the impact on infection or 
disease and/or look at how a program is functioning. For example, an intervention program may not 
show a reduction in disease but may result in an improved capacity for detection or impact on the 
effectiveness of the overall program. Secondary indicators include activities such as training and 
supervision, timeliness of reporting and education session or workshop attendance. 
Contribution of this review 
This review aims to provide a critical review of published evidence that evaluates the effectiveness of 
community-based surveillance and prevention and control interventions for emerging zoonotic 
infectious diseases. In addressing the three research questions outlined above we will analyse not 
only the effectiveness of community surveillance and prevention and control interventions in SE Asia 
Intervention: 
signal surveillance 
hygiene education 
voluntary isolation 
farming practices 
Behavioural 
mechanisms: 
values, beliefs & 
experiences of 
community  
Context: 
economic 
social 
political 
Outcomes: 
infection 
disease 
morbidity 
mortality 
Figure 1: The effects of interventions on outcomes are mediated by context and 
behavioural mechanisms 
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in identifying and responding to these infectious diseases, but also explore the contextual factors that 
influence their success. 
Inclusion criteria 
Types of participants 
As mentioned above, the control of infectious diseases in resource constrained settings is more likely 
to be influenced by community-based and behavioural change interventions. This review will consider 
studies that evaluate infectious disease surveillance and control interventions that are non-
pharmaceutical, non-vaccine, and community-based. Community-based is defined as implemented 
outside a healthcare institution with at least one component of the intervention targeted directly at the 
community (e.g. educational meetings, involvement of local leaders). Interventions with no community 
participation (i.e. top-down vector control programmes) will be excluded as they are outside the scope 
of this project.  
This review will consider studies conducted in communities in Southeast Asian countries. We define 
SE Asia as the ten member countries of the Association of Southeast Asian Nations (ASEAN). 18 The 
ASEAN countries are Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, 
Singapore, Thailand, and Vietnam. 
We will include studies which report on interventions to prevent the following zoonotic emerging and 
re-emerging infections. This list has been developed from the list of emerging and re-emerging 
zoonotic infections published on the CDC website 19 as commonly occurring in SE Asia: 
 Avian Influenza 
 Dengue Fever 
 Nipah Virus 
 Severe Acute Respiratory Syndrome 
 Rabies 
Types of intervention(s)/phenomena of interest 
On the basis of preliminary searches identifying the following types of intervention, interventions of 
interest will include, but not be limited to: 
Surveillance Interventions: syndromic surveillance programs, communications programs, 
training/education of health workers and community workers to detect and/or prevent disease, local 
level surveillance & response teams, web surveillance. Following the One Health 20 concept of a 
synergistic approach to health we will also include animal/livestock surveillance systems where they 
are specifically evaluated with respect to their impact on human health and disease outcomes. 
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Control Interventions (subcategorised into the following): 
Health promotion interventions: self-reporting of suspected infections, promotion of voluntary self 
isolation, advocating use/provision of personal protective equipment, e.g. masks, public/community 
education on hygiene and respiratory etiquette, safe slaughter and preparation of animals and animal 
products (in particular poultry),  
Physical interventions: contact tracing, isolation, quarantine, social distancing, barriers, 
school/workplace closure, movement restriction,  
Environmental interventions: environmental cleaning, waste disposal, coverage or removal of water 
containers, vector control, larval control including larvivorous fish and copepods, destruction of 
potentially infected animals and animal products 
Types of outcomes 
A range of different outcomes used in the studies will be examined. For the purposes of this review, 
they can be broadly categorised into primary and secondary outcomes. Primary outcomes aim to 
measure the incidence of infection or disease in the community. As such we will report on data on 
rates of infection, disease or outbreaks. We will consider studies that report any type of quantitative 
infection/disease/outbreak outcome data. From preliminary searches, we anticipate the inclusion of 
the following types of primary outcome measures: 
Primary outcomes: rates of infection, numbers of cases of infection reported and confirmed, 
mortality rates attributable to the infectious disease, rates of hospitalisation attributable to the 
infectious disease, number of outbreaks, time/size of epidemic peak, duration of outbreak/epidemic. 
To help contextualise our findings and address review question three, we will also extract any 
information on indicators relating to timely and adequate identification and containment of outbreaks 
and/or improved capacity for disease control. We will categorise indicators based around the WHO 
framework for the monitoring and evaluation of surveillance and response systems for communicable 
disease 21 and categorise these as secondary outcomes:  
Secondary outcomes: 
 Process indicators: Activities such as training, supervision, developing guidelines and core 
surveillance functions undertaken, 
 Output indicators: The results of the activities conducted e.g. proportion of surveillance 
centres providing timely reporting, number of households with containers covered, proportion 
of the community attending education session, 
 Outcome indicators: The extent to which the surveillance and response objectives are being 
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achieved, including the quality of the surveillance systems and the appropriateness of any 
outbreak response e.g. proportion of outbreaks where appropriate control response initiated, 
incidence-reporting-response times, numbers of larvae/vectors, improvements in knowledge 
relating to hygiene education campaigns. 
Note that the fifth category under this framework is Impact indicators (the extent to which the overall 
goal of the surveillance and response systems is being achieved) which are considered as the main 
outcomes of our review and discussed above. 
Types of studies 
Following the recommendations of the Cochrane Effective Practice and Organisation of Care Review 
Group (EPOC) 22, which is concerned with evaluating interventions in community healthcare settings, 
only studies that provide evidence that draws a comparison between an intervention setting and a 
non-intervention setting will be included. A second inclusion criterion is that the study must report 
results as quantitative infection/disease/outbreak data (as described under types of outcomes). We 
aim to include studies reporting original primary data or systematic reviews of this type of evidence 
(i.e. not theoretical model based studies). 
Acceptable study designs will include: systematic reviews/meta-analyses, randomised controlled 
trials, controlled clinical trials, controlled before and after trials, interrupted time series (we will require 
only one time point before and after the intervention). We will also accept mixed-method studies that 
include one of the above, and systematic review and economic evaluations that are based on one of 
the above. Conference papers, clinical observations, program reports with only one time point and 
non-systematic overview articles will be excluded. 
The quantitative component of the review will extract data from included studies on all disease 
outcomes and process indicators measured. This information will be used to address review 
questions 1 and 2.  
The textual component of the review will consider the textual information included in the introduction, 
methods and discussion of all papers included in the quantitative review. This will be used to 
supplement the quantitative information on process indicators and address review question 3. 
Search strategy 
The search strategy aims to find published studies. A three-step search strategy will be utilised in this 
review. An initial limited search of MEDLINE and CINAHL will be undertaken followed by analysis of 
the text words contained in the title and abstract, and of the index terms used to describe article. A 
second search using all identified keywords and index terms will then be undertaken across all 
included databases. Finally, the reference list of all identified reports and articles will be searched for 
9 
 
additional studies.  
Studies published in any language with an abstract available in English will be considered for 
inclusion in this review. Studies will be assessed for inclusion based on title and abstract only; with 
studies only translated if they meet inclusion criteria. Studies published between 1980 and 2011 will 
be considered for inclusion in this review. A start date of 1980 has been chosen as surveillance 
programs in most Southeast Asian countries commenced in the early 1990s. By including data from 
1980, we hope to capture any information on community-based surveillance and intervention 
programs that may have contributed to the development of formal surveillance programs.23-27 
The databases to be searched include: PubMed, CINAHL, ProQuest, EBSCOhost, Web of Science, 
Science Direct, the Cochrane database of systematic reviews, the WHO library database (WHOLIS), 
British Development Library, LILACS, World Bank (East Asia) and the Asian Development Bank. 
Keywords for the search will reflect i) disease terms, ii) intervention terms and iii) countries of interest; 
and will be combined systematically as [disease terms] + [intervention terms] + [countries]. 
Initial keywords: 
“influenza”, “avian influenza”, “dengue” ,“haemorrhagic fever” “severe acute respiratory syndrome”, 
“SARS”, “Nipah virus”, “rabies”, “communicable disease”, “infectious disease”, “zoonotic”, “emerging 
infectious disease”, re-emerging infectious disease”, “infectious disease outbreak”, “infectious disease 
transmission”, “pandemic”, “epidemic”, “infectious disease response”, “infectious disease control”, 
“pigs”, “bats”, “NOT malaria” 
“disease notification”, “surveillance”, “syndromic surveillance”, “electronic surveillance”, “web 
surveillance”, “local surveillance” 
“infection control”, “contact tracing”, “patient isolation”, “voluntary isolation” “quarantine”, “personal 
protective equipment” , “protective devices”, “masks”, “protective clothing”, “gloves”, “respiratory 
protective devices”, “prevention and control”, “hygiene” , “school closure”, “animal handling”, ”infected 
animals”, “breeding places”, ”water storage”, “hand washing”, “sneezing”, larval control”, “vector 
control”, “education”, “health behaviour”, “health promotion”, 
“community organisation”, “community initiative”, “community intervention”, “community workers”, 
“public health” “household” “school-based” “NOT pharmaceuticals”, “NOT vaccine” 
“evaluation”, “effectiveness”, “efficacy”, “sustainability”, “responsiveness”, “acceptability”, “flexibility” 
“South east Asia”, ”Thailand”, “Singapore”, “Laos”, “Malaysia”, “Brunei”, “Myanmar”, “Burma” 
“Philippines”, “Indonesia”, “Cambodia”, ”Viet Nam” 
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Assessment of methodological quality 
Infectious disease surveillance and control interventions are hard to evaluate given the spontaneous 
and random nature with which infections occur. Evaluations may not therefore provide conclusive 
evidence for or against an intervention. Evidence particularly in a developing country context will 
predominantly be available from epidemiological studies, which are more prone to bias than 
randomised controlled trials. To minimise threats to the validity of this review and maximise the 
information extracted from it we propose the following methods. 
Quantitative papers selected for retrieval will be assessed by two independent reviewers for 
methodological validity prior to inclusion in the review using standardised critical appraisal instruments 
from the Joanna Briggs Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-
MAStARI) (Appendix I). Any disagreements that arise between the reviewers will be resolved through 
discussion, or with a third reviewer. 
We anticipate that for some study designs that are not covered by the standardised JBI instruments 
we will use alternative appraisal instruments (Appendix II and III). We have identified extra appraisal 
instruments for the following study designs: 
 cost-effectiveness evaluations  
 mixed-methods studies 
 systematic reviews/meta-analyses 
Data collection 
Quantitative data will be extracted from papers included in the review using standardised data 
extraction tools from JBI-MAStARI. The data extracted will include specific details about the 
interventions, populations, and study methods, programme theory and other outcomes of significance 
to the review question and specific review objectives. This will include both disease outcomes and 
process indicators as described above to enable us to look at both the effectiveness and function of 
the programs.  
To enable us to comment better on why programs have been (un)successful, we will collect both 
quantitative data (i.e. process indicators) and qualitative data constituting narrative evidence or 
speculation by the authors on why interventions have been effective or not and any comment on 
sustainability. The textual data will be extracted from the papers included in the quantitative review to 
capture the following specific details about the context and mechanisms of the program relevant to 
the review question and specific objectives:  
 Features of the study setting, i.e. the geographical setting, the social, cultural and political 
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context, the season, 
 Features of the interventions i.e. what was done, how it was delivered, who was targeted, 
where it was delivered and by whom, funding organisation, technical and financial program 
details and any behavioural mechanisms targeted by the intervention, 
 Level of participants i.e. communities, households, individuals, details on age and gender. 
Data synthesis 
Quantitative papers will, where possible be pooled in statistical meta-analysis using JBI-MAStARI.  If 
both numerator and denominator infection data is available we will examine this as binomial data (e.g. 
number alive divided by number treated). Otherwise, effect sizes expressed as weighted mean 
differences (for continuous data) and odds ratio (for categorical data) and their 95% confidence 
intervals will be calculated for analysis. Heterogeneity will be assessed statistically using the standard 
Chi-square and also explored using subgroup analyses. Subgroup analyses will be performed on 
grouping based on the different interventions, diseases, contexts and study designs included in this 
review. Where statistical pooling is not possible the findings will be presented in narrative form 
including tables and figures to aid in data presentation where appropriate. 
Data extracted regarding the factors that aided or impeded the effectiveness of a specific intervention 
will be synthesised in narrative summary with the aid of tables and figures. We will use the 
frameworks for evaluating infectious disease surveillance systems and behavioural interventions 
outlined in the background section to guide categorisation in our synthesis of this evidence. For 
surveillance activities we will group abstracted information according to the CDC criterion for 
evaluating surveillance activities and for control programmes we will use the behavioural change 
framework to look at mechanisms and context for change.  
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Appendix II - Source of additional appraisal instruments 
 
Systematic reviews  
http://www.sph.nhs.uk/sph-files/S.Reviews%20Appraisal%20Tool.pdf 
Economic evaluations  
http://www.sph.nhs.uk/sph-files/Economic Evaluations 10 Questions.pdf  
Mixed methods studies 
http://usir.salford.ac.uk/12969/1/Evaluation_Tool_for_Quantitative_Research_Studies.pdf 
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Appendix III - Data extraction instruments 
 
Data extraction tool for experimental/observational studies 
 
Data Extraction Table ‐ Surveillance 
Reviewer 
Date 
Publication details 
Authors; Year 
Publication details 
Study details 
Study design 
Prospective/retrospective 
Independent evaluation 
Sample size 
Type of intervention 
Contextual Factors 
Study Setting 
Country & region 
Religion/language (including whether homogenous) 
Socioeconomic context 
Health system structure & access factors identified by 
authors (e.g. access to facilities, hierarchical delivery system, 
level of out‐of‐pocket costs) 
Geographical/spatial/temporal/climatic context 
Local profile of infectious disease e.g. endemic, epidemic, 
seasonal 
Participants   
Participants (age/gender) 
Details of community groups involved 
Relationship between individuals delivering program & 
participating in program 
Program details 
Program dates & season 
Infectious diseases targeted 
Core elements of program 
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Behavioural mechanisms identified by authors 
Program theory identified by authors 
Methods for program delivery 
Who delivered program 
Resources required for program delivery 
Source of program funding 
Program partners (other organisations/departments) 
Interaction with other infection surveillance/control systems 
Outcomes 
Indicators 
Process indicators reported by authors (e.g. Proportion of 
centres providing timely response,  
Output indicators reported by authors (e.g. Proportion of 
population covered, participant knowledge & attitude 
scores, ) 
Outcomes 
Infection outcomes reported by authors (e.g. Incidence rates, 
prevalence rates, number of outbreaks, number of 
secondary cases) 
Disease outcomes reported by authors (e.g. Morbidity, 
mortality, economic outcomes) 
Contributing factors 
Factors contributing to program success specifically 
identified by authors 
Evidence to support this: unequivocal / credible /  
unsupported 
Factors contributing to program failure specifically identified 
by authors 
Evidence to support this: unequivocal / credible /  
unsupported 
Conclusions 
Authors conclusions 
Valid based on study results: unequivocal / credible /  
unsupported 
Reviewers conclusions 
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Data Extraction Table ‐ Prevention & Control 
Reviewer 
Date 
Publication details 
Authors; Year 
Publication details 
Contextual Factors 
Study details 
Study design 
Prospective/retrospective 
Independent 
Sample size 
Type of intervention 
Study Setting 
Country & region 
Religion/language (including whether homogenous) 
Health system factors 
Geographical/spatial/temporal/climatic context 
Local profile of infectious disease e.g. endemic, epidemic, 
seasonal 
Participants   
Participants (age/gender) 
Details of community groups involved 
Relationship between individuals delivering program & 
participating in program 
Program details 
Program dates & season 
Infectious diseases targeted 
Core elements of program 
Behavioural mechanisms identified by authors 
Program theory identified by authors 
Methods for program delivery 
Who delivered program 
Resources required for program delivery 
Source of program funding 
Program partners (other organisations/departments) 
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Interaction with other infection surveillance/control systems 
Outcomes 
Indicators 
Process indicators reported by authors (e.g. Proportion of 
centres providing timely response,  
Output indicators reported by authors (e.g. Proportion of 
population covered, participant knowledge & attitude 
scores, ) 
Outcomes 
Infection outcomes reported by authors (e.g. Incidence rates, 
prevalence rates, number of outbreaks, number of 
secondary cases) 
Disease outcomes reported by authors (e.g. Morbidity, 
mortality, economic outcomes) 
Contributing factors 
Factors contributing to program success specifically 
identified by authors 
Factors contributing to program failure specifically identified 
by authors 
Conclusions 
Authors conclusions 
Reviewers conclusions 
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